12 June 2017 - The Senate health committee will finally train its spotlight on the high cost of prescription drugs in a highly anticipated public hearing Tuesday, the first major congressional examination of the issue since President Trump took office buoyed in part by his promises to lower prices.
Trump famously accused pharmaceutical companies of “getting away with murder” in January — but don’t expect the panel to be a slugfest.